MA54292A - Méthodes de traitement d'un lymphome folliculaire - Google Patents

Méthodes de traitement d'un lymphome folliculaire

Info

Publication number
MA54292A
MA54292A MA054292A MA54292A MA54292A MA 54292 A MA54292 A MA 54292A MA 054292 A MA054292 A MA 054292A MA 54292 A MA54292 A MA 54292A MA 54292 A MA54292 A MA 54292A
Authority
MA
Morocco
Prior art keywords
methods
follicular lymphoma
treating follicular
treating
lymphoma
Prior art date
Application number
MA054292A
Other languages
English (en)
French (fr)
Inventor
Sriram Balasubramanian
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of MA54292A publication Critical patent/MA54292A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MA054292A 2018-11-30 2019-11-26 Méthodes de traitement d'un lymphome folliculaire MA54292A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862773678P 2018-11-30 2018-11-30

Publications (1)

Publication Number Publication Date
MA54292A true MA54292A (fr) 2021-10-06

Family

ID=68966021

Family Applications (1)

Application Number Title Priority Date Filing Date
MA054292A MA54292A (fr) 2018-11-30 2019-11-26 Méthodes de traitement d'un lymphome folliculaire

Country Status (16)

Country Link
US (1) US20200171034A1 (https=)
EP (1) EP3886992A1 (https=)
JP (1) JP2022513666A (https=)
KR (1) KR20210097160A (https=)
CN (1) CN113164782A (https=)
AU (1) AU2019388899A1 (https=)
BR (1) BR112021009978A2 (https=)
CA (1) CA3120960A1 (https=)
EA (1) EA202191509A1 (https=)
IL (1) IL283365A (https=)
JO (1) JOP20210126A1 (https=)
MA (1) MA54292A (https=)
MX (1) MX2021006368A (https=)
PH (1) PH12021551140A1 (https=)
SG (1) SG11202105309YA (https=)
WO (1) WO2020112761A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2983670A4 (en) * 2013-04-08 2017-03-08 Pharmacyclics LLC Ibrutinib combination therapy
CA2914284A1 (en) * 2013-05-30 2014-12-04 Infinity Pharmaceuticals, Inc. Treatment of cancers using pi3 kinase isoform modulators
US20160032404A1 (en) * 2014-08-01 2016-02-04 Pharmacyclics Llc Biomarkers for predicting response of dlbcl to treatment with a btk inhibitor
CA2980393A1 (en) * 2015-03-18 2016-09-22 Memorial Sloan Kettering Cancer Center Methods for diagnosing and treating follicular lymphoma
HK1250925A1 (zh) * 2015-04-06 2019-01-18 Janssen Pharmaceutica, N.V. 包含依鲁替尼的组合物
WO2017087947A2 (en) * 2015-11-19 2017-05-26 Pharmacyclics Llc Method of treatment of follicular lymphoma with a btk inhibitor
PH12021551936A1 (en) * 2019-02-15 2022-05-23 Janssen Biotech Inc Combination therapy for treatment of b-cell malignancies

Also Published As

Publication number Publication date
CN113164782A (zh) 2021-07-23
JOP20210126A1 (ar) 2019-11-26
SG11202105309YA (en) 2021-06-29
KR20210097160A (ko) 2021-08-06
EP3886992A1 (en) 2021-10-06
US20200171034A1 (en) 2020-06-04
JP2022513666A (ja) 2022-02-09
EA202191509A1 (ru) 2021-10-26
BR112021009978A2 (pt) 2021-08-17
WO2020112761A1 (en) 2020-06-04
PH12021551140A1 (en) 2021-10-25
AU2019388899A1 (en) 2021-06-10
IL283365A (en) 2021-07-29
MX2021006368A (es) 2021-10-13
CA3120960A1 (en) 2020-06-04

Similar Documents

Publication Publication Date Title
MA46954A (fr) Méthodes de traitement d'états inflammatoires
EP3813806A4 (en) Methods of treating mitochondrial dysfunction
EP3478286A4 (en) METHOD FOR TREATING OVARY CANCER
MA56212A (fr) Compositions et méthodes de traitement du cancer
MA53329A (fr) Méthodes de traitement de l'épilepsie
EP3506944A4 (en) COMPOSITIONS AND METHODS FOR TREATING TUMOR SUPPRESSOR-DEFICIENT CANCER
EP3801578A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF C. DIFFICILE
MA53506A (fr) Méthodes de traitement du cancer avec des inhibiteurs de pd-l1 à petites molécules
EP3432891A4 (en) METHOD FOR THE TREATMENT AND PREVENTION OF C. DIFFICILE
EP3423100A4 (en) COMPOSITIONS FOR THE TREATMENT OF INFLAMMATION AND METHOD FOR THE TREATMENT THEREOF
EP3285776A4 (en) METHOD FOR TREATING BACTERIAL INFECTIONS
EP3775263A4 (en) COMPOSITIONS AND METHODS OF TREATING ACNE
EP3512524A4 (en) METHOD AND COMPOSITIONS FOR TREATING VIRUS INFECTIONS
EP3405191A4 (en) METHOD AND COMPOSITIONS FOR TREATING HYPERHIDROSIS
EP3458079A4 (en) COMPOSITIONS AND METHODS FOR TREATING ACNE
MA47504A (fr) Composés et méthodes de traitement de l'angiocholite biliaire primitive
EP3773632A4 (en) METHODS OF TREATMENT OF EGFRVIII-EXPRESSING GLIOBLASTOMA
EP3651801A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OF MUSHROOM INFECTION
MA55093A (fr) Méthodes et compositions pour le traitement du cancer
EP3787625A4 (en) METHODS OF TREATMENT OF CANCER
EP3775171A4 (en) METHODS OF TREATMENT OF MINIMAL RESIDUAL CANCER
EP3829619A4 (en) TREATMENT OF IVA MUCOPOLYSACCHARIDOSIS
IL281775A (en) Methods of treatment of infections using bacteria
EP3849605A4 (en) METHODS OF TREATMENT OF PANCREATITIS
EP3713576A4 (en) METHOD OF CANCER THERAPY